Vectura Group Plc VEC-Financial and Strategic SWOT Analysis Review

Vectura Group Plc VEC-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH7949FSA
  • |
  • Pages: 56
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Vectura Group Plc (VEC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vectura Group Plc (Vectura) is a product development company that develops inhaled pharmaceutical therapies. The company offers its products for the treatment of airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases of the lung. It also develops products for the treatment of respiratory diseases based on a wide range of proprietary lung delivery technologies, including device and formulation capabilities. The company offers formulation and device technologies to other pharmaceutical companies on an out-licensing basis. It has a wide range of pipeline products in clinical and pre-clinical development stages. Vectura is headquartered in Chippenham, Wiltshire, the UK.

Vectura Group Plc Key Recent Developments

Jun 10, 2016: Vectura Group announces Directorate Changes

May 26, 2016: Vectura Group-Preliminary Results for twelve months ending 31 March 2016

Jun 24, 2015: Vectura Appoints James Ward-Lilley as CEO

Jun 24, 2015: Vectura Group: Appoints James Ward-Lilley as CEO

Jun 04, 2015: Vectura Group announces Phase I clinical study commences

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Vectura Group Plc-Key Facts 6

Vectura Group Plc-Key Employees 7

Vectura Group Plc-Key Employee Biographies 8

Vectura Group Plc-Major Products and Services 9

Vectura Group Plc-Pharmaceutical Pipeline Products Data 11

Vectura Group Plc, Pipeline Products by Therapy Area 11

Vectura Group Plc, Pipeline Products by Development Phase 12

Vectura Group Plc-History 14

Vectura Group Plc-Company Statement 18

Vectura Group Plc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 20

Section 2-Company Analysis 21

Vectura Group Plc-Business Description 21

Vectura Group Plc-Corporate Strategy 23

Vectura Group Plc-SWOT Analysis 24

SWOT Analysis-Overview 24

Vectura Group Plc-Strengths 24

Strength-Proprietary Platform, Technologies and Devices 24

Strength-Research and Development Activities 24

Strength-Device and Development Services 24

Vectura Group Plc-Weaknesses 25

Weakness-Product Discontinuation 25

Weakness-Dependence on Royalty Revenues 25

Vectura Group Plc-Opportunities 26

Opportunity-Product Pipeline 26

Opportunity-Strategic Agreements 26

Opportunity-Business Combination 26

Vectura Group Plc-Threats 27

Threat-Stringent Government Regulations 27

Threat-Intense Competition 27

Threat-Customer Concentration 27

Vectura Group Plc-Key Competitors 28

Section 3-Company Financial Ratios 29

Financial Ratios-Capital Market Ratios 29

Financial Ratios-Annual Ratios 30

Performance Chart 31

Financial Performance 31

Financial Ratios-Interim Ratios 32

Financial Ratios-Ratio Charts 33

Section 4-Company's Lifesciences Financial Deals and Alliances 34

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 34

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 35

Vectura Group Plc, Recent Deals Summary 36

Section 5-Company's Recent Developments 37

Jun 10, 2016: Vectura Group announces Directorate Changes 37

May 26, 2016: Vectura Group-Preliminary Results for twelve months ending 31 March 2016 38

Jun 24, 2015: Vectura Appoints James Ward-Lilley as CEO 45

Jun 24, 2015: Vectura Group: Appoints James Ward-Lilley as CEO 46

May 20, 2015: Vectura Group Announces Preliminary Results 47

Apr 01, 2015: Vectura Group Announces Appointment Of Non-Executive Director 50

Feb 03, 2015: Vectura Group announces Chief Executive's intention to step down 51

Section 6-Appendix 52

Methodology 52

Ratio Definitions 52

About GlobalData 56

Contact Us 56

Disclaimer 56

List of Figures

Vectura Group Plc, Pipeline Products by Therapy Area 11

Vectura Group Plc, Pipeline Products by Development Phase 12

Vectura Group Plc, Performance Chart (2012-2016) 31

Vectura Group Plc, Ratio Charts 33

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 34

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 35

List of Tables

Vectura Group Plc, Key Facts 6

Vectura Group Plc, Key Employees 7

Vectura Group Plc, Key Employee Biographies 8

Vectura Group Plc, Major Products and Services 9

Vectura Group Plc, Number of Pipeline Products by Therapy Area 11

Vectura Group Plc, Number of Pipeline Products by Development Stage 12

Vectura Group Plc, Pipeline Products By Therapy Area and Development Phase 13

Vectura Group Plc, History 14

Vectura Group Plc, Subsidiaries 20

Vectura Group Plc, Joint Venture 20

Vectura Group Plc, Key Competitors 28

Vectura Group Plc, Ratios based on current share price 29

Vectura Group Plc, Annual Ratios 30

Vectura Group Plc, Interim Ratios 32

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 34

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 35

Vectura Group Plc, Recent Deals Summary 36

Currency Codes 52

Capital Market Ratios 52

Equity Ratios 53

Profitability Ratios 53

Cost Ratios 54

Liquidity Ratios 54

Leverage Ratios 55

Efficiency Ratios 55

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Vernalis Plc

SkyePharma Plc

GlaxoSmithKline Plc

Consort Medical plc

AstraZeneca Plc

Vectura Group Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8010
Site License
USD 250 INR 16020
Corporate User License
USD 375 INR 24030

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com